OSTEOPATIJOS CENTRAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 37,686 | 32,460 | 30,930 | 36,310 | 40,655 | 50,100 | 56,040 | 56,660 |
| Profit before tax | 1,954 | -2,853 | -2,124 | -2,305 | -2,862 | 610 | 1,505 | 6 |
| Net profit | 1,856 | -2,853 | -2,124 | -2,305 | -2,862 | 610 | 1,505 | 6 |
| Equity | 7,788 | 4,935 | 2,811 | 505 | -2,357 | -1,747 | -241 | -235 |
| Liabilities | 1,020 | 1,030 | 2,073 | 3,588 | 5,114 | 5,284 | 7,035 | 7,623 |
| Non-current assets | 735 | 277 | 1 | 1 | 1 | 1 | 417 | 266 |
| Current assets | 7,980 | 5,688 | 4,883 | 4,022 | 2,686 | 3,466 | 6,307 | 7,052 |
| Total assets | 8,715 | 5,965 | 4,884 | 4,023 | 2,687 | 3,467 | 6,724 | 7,318 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,985 | 4,942 | 5,578 |
| Social insurance contributions | - | - | - | - | - | 6,191 | 6,777 | 7,529 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.3% | -13.9% | -4.7% | +17.4% | +12.0% | +23.2% | +11.9% | +1.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 21.3% | -47.8% | -43.5% | -57.3% | -106.5% | 17.6% | 22.4% | 0.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.8% | -57.8% | -75.6% | -456.4% | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.9% | -8.8% | -6.9% | -6.3% | -7.0% | 1.2% | 2.7% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.2% | -8.8% | -6.9% | -6.3% | -7.0% | 1.2% | 2.7% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | 0.7 | 7.1 | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,229 | 8,115 | 7,733 | 9,078 | 9,382 | 10,020 | 12,008 | 14,165 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
OSTEOPATIJOS CENTRAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-16 | 2026-01-18 | 1.82 |
| 2024-12-22 | 2024-12-29 | 55.93 |
| 2024-12-17 | 2024-12-20 | 55.93 |
| 2024-10-16 | 2024-10-20 | 55.78 |
| 2024-05-16 | 2024-05-19 | 243.07 |
| 2024-03-18 | 2024-03-19 | 242.42 |
| 2024-02-19 | 2024-02-21 | 134.54 |
| 2023-03-16 | 2023-03-19 | 46.45 |
OSTEOPATIJOS CENTRAS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
OSTEOPATIJOS CENTRAS, UAB (code 302869933) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated revenue of €56.7K and net profit of €6, resulting in a near-zero profit margin. Revenue increased by 1.1% year on year and by 13.1% over two years, showing gradual top-line growth. The profit trajectory was more uneven: net profit was €610 in 2023, rose to €1.5K in 2024, and then fell sharply in 2025. The balance sheet remained small, with total assets of €7.3K, liabilities of €7.6K, and negative equity of €235. Short-term assets made up most of the asset base at €7.1K, while long-term assets were €266. Key ratios should be interpreted cautiously in light of negative equity, but reported metrics show ROE of -2.5%, ROA of 0.1%, debt-to-equity of -32.44, and asset turnover of 7.74x. Revenue per employee was €14.2K, and profit per employee was €2.